The voters did not hire Elon Musk, and no amount of spin will wipe away the fact he almost drove the government into shutdown ...

But the move to strip public employees of affordable access to GLP-1s for weight loss is not only significant for those currently taking these drugs but ... insurers may not cover these ...

Liam Payne’s drug usage brought him “close to death” multiple times months before his fatal fall in October, according to his friend Roger Nores. In a 91-page filing obtained today by ...

A total of 82 drugs have failed quality tests so far in 2024, according to the Medical Supplies Division of the Health Ministry. Of the drugs that have failed quality tests, about 39 were ...

The fall of Syria’s Bashar al-Assad overturned the most profitable drug-smuggling network in the Middle East, exposing the former regime’s role in manufacturing and trafficking pills that ...

A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 ...

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

Many Part C plans include prescription drug (Part D) coverage. In these cases, Part C may also cover an eligible medication abortion using misoprostol. Some Part C plans include additional health ...

(Reuters) - The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen (NASDAQ:BIIB)'s amyotrophic lateral sclerosis drug Qalsody ...

Property News: Revealed – Australia's cheapest and most expensive streets of 2024. © 2024 Nine Entertainment Co.

Shares of companies owning pharmacy benefit managers fell on Wednesday after the introduction of a bipartisan bill that would force health insurers or drug middlemen to divest their pharmacy ...

Weight-loss drugs could be a boon for insurers, but it is too soon to tell whether the industry will be transformed, the head of Swiss Re’s life and health reinsurance arm said. The market for ...